PCSK9 and familial hypercholesterolemia: Moreover, it is conceivable that adjustment of dose levels and schedules could further increase editing rates in macaques to those observed in mice, making the PCSK9 base editing approach reported here also suitable for treating patients with familial hypercholesterolemia.